COETTA NEECE: Open Payments
NPI 1578800967 · GRUNDY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 16 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $329 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| Alkermes, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $28 |
Products named: CAPLYTA, COBENFY, SPRAVATO, ARISTADA, INGREZZA, Auvelity.
Industry payments across VA — which companies pay providers there.
